Inventor
Daniel H. BYUN
Inventor
US
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
A61KPreparations for medical, dental or toiletry purposes23%
C07DHeterocyclic compounds21%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium17%
C07BGeneral methods of organic chemistry9%
C07HSugars2%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
12,448,383Compounds and methods for treatment of viral infections202512,410,160KHK inhibitors202512,404,2891'-cyano nucleoside analogs and uses thereof202512,240,862Inhibitors of peptidylarginine deiminases202512,180,217Compounds and methods for treatment of viral infections202412,110,305Prodrugs of phosphonamide nucleotide analogues and their pharmaceutical use202412,030,903Antiviral compounds202411,939,3471'-cyano nucleoside analogs and uses thereof202411,878,965Inhibitors of peptidylarginine deiminases202411,851,4381'-cyano nucleoside analogs and methods for treatment of viral infections202311,845,755Compounds and methods for treatment of viral infections202311,780,844Compounds and methods for treatment of viral infections202311,718,637Prodrugs of 4'-C-substituted-2-halo-2'- deoxyadenosine nucleosides and methods of making and using the same2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to GILEAD SCIENCES INC (13)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 13 | 2023–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 13 | 2023–2025 |